Publication

Article

Generic Supplements
Volume 0
0

dual path

Articles in this issue
Aggressive lipid lowering superior to usual care in a real-world setting: The ALLIANCE study
dual path
Exam
Dual inhibition effective and safe in clinical practice: The EASE study
Managed Care Commentary:MCOs face new challenges
Phytosterols may play role in atherosclerosis
Blocking intestinal cholesterol absorption for optimal lipid lowering
Dual pathway inhibition: Attacking cholesterol on two fronts
Beyond ATP III-Impact of recent clinical trials on future lipid management guidelines and therapeutic goals
Future Goals, Targets, and Treatments of Dyslipidemia
Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
Related Content
RSV vaccine vial with syringe - Respiratory syncytial virus shot - Image credit: MargJohnsonVA | stock.adobe.com
October 22nd 2024

Educate Patients About Changing Adult RSV Vaccine Recommendations

Adam James, PharmD
Solid tumor -- Image credit: Yuriy | stock.adobe.com
October 22nd 2024

Introducing Tarlatamab-dlle: A New Era in Oncology Treatment

Amir Ali, PharmD, BCOP Phoebe Kim, PharmD Candidate Stacey Cheung, PharmD Candidate Samantha Shi, PharmD, BCOP Harry Shamamian, PharmD, MBA, FACHE Hien Tang, PharmD, BCOP
Fatigued mature old man taking off glasses suffering from tired dry irritated eyes after long computer use, senior middle aged male feels eye strain problem or blurry vision working on laptop at home - Image credit: fizkes | stock.adobe.com
October 21st 2024

Advise Patients About Routine Ophthalmic Health

Yvette C. Terrie, BSPharm, RPh
Health care professional and patient -- Image credit: thatinchan | stock.adobe.comHealth care professional and patient -- Image credit: thatinchan | stock.adobe.com
October 21st 2024

Review of 3 Alternative Pathways to Access Non–FDA-Approved Drugs

Emily Hennes, PharmD, BCOP Berrie Child, PharmD, BCOP Stefanie Conley, PharmD, BCOP Dina Dumercy McHenry, PharmD, MBA, BCOP, CSSGB Sarah Lentz, BCOP Camille Smith, PharmD, DPLA, CCRP Jennifer Murphy, PharmD, BCOP
Acute lymphocytic leukemia -- Image credit: jarun011 | stock.adobe.com
October 18th 2024

Inotuzumab Ozogamicin in Pediatric Patients With Relapsed or Refractory B-Cell ALL

Basmah Zahid, PharmD, MS
October 2024 Product News
October 18th 2024

October 2024 Product News

PT Staff